| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
LABS Stock Overview
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada, Australia, Germany, and internationally.
MediPharm Labs Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.08 |
| 52 Week High | CA$0.23 |
| 52 Week Low | CA$0.06 |
| Beta | 1.04 |
| 1 Month Change | 14.29% |
| 3 Month Change | 6.67% |
| 1 Year Change | -57.90% |
| 3 Year Change | -97.65% |
| 5 Year Change | n/a |
| Change since IPO | -96.36% |
Recent News & Updates
Recent updates
Time To Worry? Analysts Just Downgraded Their MediPharm Labs Corp. (TSE:LABS) Outlook
Aug 20
Some Analysts Just Cut Their MediPharm Labs Corp. (TSE:LABS) Estimates
May 21Things Look Grim For MediPharm Labs Corp. (TSE:LABS) After Today's Downgrade
Apr 06Is MediPharm Labs (TSE:LABS) Using Too Much Debt?
Mar 07Does MediPharm Labs (TSE:LABS) Have A Healthy Balance Sheet?
Aug 18Some MediPharm Labs Corp. (TSE:LABS) Analysts Just Made A Major Cut To Next Year's Estimates
May 23Reflecting on MediPharm Labs' (TSE:LABS) Share Price Returns Over The Last Year
Jan 11
Shareholder Returns
| LABS | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | -5.9% | -4.7% | -2.4% |
| 1Y | -57.9% | -53.2% | -3.2% |
Return vs Industry: LABS underperformed the Canadian Pharmaceuticals industry which returned -46.8% over the past year.
Return vs Market: LABS underperformed the Canadian Market which returned -3.4% over the past year.
Price Volatility
| LABS volatility | |
|---|---|
| LABS Average Weekly Movement | 13.6% |
| Pharmaceuticals Industry Average Movement | 14.6% |
| Market Average Movement | 9.9% |
| 10% most volatile stocks in CA Market | 18.4% |
| 10% least volatile stocks in CA Market | 4.1% |
Stable Share Price: LABS is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 14% a week.
Volatility Over Time: LABS's weekly volatility (14%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | 190 | David Pidduck | https://www.medipharmlabs.com |
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada, Australia, Germany, and internationally. It formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products. The company also provides GMP flower sourcing, packaging, and distribution services.
MediPharm Labs Corp. Fundamentals Summary
| LABS fundamental statistics | |
|---|---|
| Market Cap | CA$22.57m |
| Earnings (TTM) | -CA$46.14m |
| Revenue (TTM) | CA$22.24m |
1.0x
P/S Ratio-0.5x
P/E RatioIs LABS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LABS income statement (TTM) | |
|---|---|
| Revenue | CA$22.24m |
| Cost of Revenue | CA$27.79m |
| Gross Profit | -CA$5.54m |
| Other Expenses | CA$40.60m |
| Earnings | -CA$46.14m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.16 |
| Gross Margin | -24.91% |
| Net Profit Margin | -207.43% |
| Debt/Equity Ratio | 1.7% |
How did LABS perform over the long term?
See historical performance and comparison